Eurandlab SRL
Eurandlab reported total assets of 27,845 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Aug 2026).
The score of Eurandlab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -67 %
Accounts of the company itself (not consolidated).
The full file covers 13 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Eurandlab's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Aug 2026
- Year ended 31 Dec 2024filed on 23 Aug 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 24 Jun 2022
Eurandlab's financial analysis
- Solvency87.8%sector median: 34.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Eurandlab
Eurandlab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0518.905.755
- VAT number
- BE0518905755
- Peppol
- Registered · 0208:0518905755 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Feb 2013
- Registered office
- 6043 Charleroi
- Latest accounts
- 2025 · filed on 29 Aug 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Eurandlab (SRL) has been based in Charleroi since 2013, active in: manufacture of medicaments. For 2025, it reports a net profit of 33,599 € and equity of 24,436 €; its revenue is not published. Its solvency stands at 87.8%, above the median of its sector (34.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Eurandlab
Companies in the same business, of comparable size and area, outside its group.
- Mountvector Bio Manufacture of pharmaceutical preparations Ottignies-Louvain-la-Neuve · balance sheet 180,416 €
- LBS Manufacture of pharmaceutical preparations Ghent · balance sheet 291,800 €
- Parc Elisabeth Pharma Manufacture of pharmaceutical preparations Ganshoren · balance sheet 296,304 €
- Quantoom Bioservices Manufacture of basic pharmaceutical products Nivelles · balance sheet 59,035 €
- Unda Manufacture of pharmaceutical preparations Aywaille · balance sheet 517,605 €
- 272BIO Manufacture of pharmaceutical preparations Ghent · balance sheet 709,601 €
- Phenix Property Manufacture of pharmaceutical preparations Hoogstraten · balance sheet €1.13m
- L - Pharma Manufacture of pharmaceutical preparations Turnhout · balance sheet 10 €
Frequently asked questions about Eurandlab
What is the revenue of Eurandlab?
Eurandlab files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Eurandlab?
In Belgium, the VAT number is the company number prefixed with BE: BE0518905755 for Eurandlab, if the company is VAT-registered. Its company number (CBE) is 0518.905.755.
Where is the registered office of Eurandlab?
According to the CBE register, the registered office of Eurandlab is in 6043 Charleroi.
What is the equity of Eurandlab?
At the close of the 2025 financial year, the equity of Eurandlab amounts to 24,436 €, a solvency of 87.8% of total assets.
Who manages Eurandlab?
The register lists 2 active mandates at Eurandlab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Eurandlab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →